Human CD272 Protein, mFc Tag
- 
									
产品编号
KMP2252
 - 
									
别名
B和T淋巴细胞衰减因子, B- and T-Lymphocyte Attenuator, CD272
 - 
									
规格
- 50ug
 - 100ug
 - 200ug
 
 
| Catalog Number | KMP2252 | 
| Alias | B和T淋巴细胞衰减因子, B- and T-Lymphocyte Attenuator, CD272 | 
| Size | 50ug, 100ug, 200ug | 
| Product Description | The Human CD272 Protein(KMP2252) is produced in HEK293 Cells and the target gene encoding Lys31-Leu150 is expressed with a mFc tag at the C-terminus. | 
| Molecular Name | CD272 | 
| Product Introduction | CD272(BTLA):免疫球蛋白超家族(IgSF)成员,通过跨膜形式参与T细胞活化的负向调控。 | 
| Molecular Weight | 13.2 kDa | 
| Expression System | HEK293 Cells | 
| Species | Human | 
| Purity | >95% | 
| SDS-PAGE | ![]()  | 
| Purification | Affinity Purification | 
| Uniprot ID | Q7Z6A9 | 
| Storage Condition | Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles. | 
| Formulation | PBS, pH7.4 | 
| Shipping Condition | In general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form. | 
| Background | B- and T-Lymphocyte Attenuator(BTLA) is a single-pass type I membrane protein containing 1 Ig-like V-type(immunoglobulin-like) domain. BTLA expression is induced during activation of T cells, and BTLA remains expressed on Th1 cells but not Th2 cells. Like PD1 and CTLA4, BTLA interacts with a B7 homolog, B7H4. However, unlike PD-1 and CTLA-4, BTLA displays T-Cell inhibition via interaction with tumor necrosis family receptors(TNF-R), not just the B7 family of cell surface receptors. BTLA is a lymphocyte inhibitory receptor that inhibits lymphocytes during immune response. BTLA also is a ligand for tumor necrosis factor(receptor) superfamily, member 14(TNFRSF14), also known as herpes virus entry mediator(HVEM). BTLA-HVEM complexes negatively regulate T-cell immune responses. | 
| Endotoxin | <1.0 EU/ug determined by the LAL method | 
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 | 
低速离心:12,000 rpm, 5分钟,去除不溶物。缓冲液置换:使用超滤离心管(如10 kDa截留分子量)浓缩。
可优化表达条件(如降低诱导温度、调整IPTG浓度)、使用促溶标签(如SUMO、GST)、共表达分子伴侣,或尝试不同宿主系统(如哺乳动物细胞或昆虫细胞)以提高可溶性蛋白产量。
							
							
							
							
						
								0